Literature DB >> 21677346

[The brain and cytokines - the mutual origin of depression, obesity and cardiovascular diseases?].

Marcin Ufnal1, Dorota Wolynczyk-Gmaj.   

Abstract

Accumulating evidence points to a pivotal role of the brain in the regulation of the circulatory system and energy balance. It has also been found that common civilization diseases such as depression, obesity, hypertension, myocardial infarction or heart failure are accompanied by an increase in concentration of inflammatory mediators in the blood, cerebrospinal fluid and various tissues. Recent studies have revealed that inflammatory mediators that are synthesized peripherally or in the brain may affect the nervous regulation of animal body systems. For example, it has been found that non-specific pro-inflammatory stimuli as well as treatment with several cytokines may cause depressive behavior, disturbances in energy balance and alterations in the circulatory system. On the other hand, knockout of genes for pro-inflammatory cytokines or administration of anti-inflammatory mediators may normalize the pathological changes. In the present manuscript we will review studies that imply the common neuroinflammatory pathogenesis of cardiovascular diseases, depression and energy balance disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21677346     DOI: 10.5604/17322693.939284

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  2 in total

1.  Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?

Authors:  Katarzyna Bliźniewska-Kowalska; Bernadeta Szewczyk; Małgorzata Gałecka; Kuan-Pin Su; Michael Maes; Janusz Szemraj; Piotr Gałecki
Journal:  J Clin Med       Date:  2020-12-12       Impact factor: 4.241

2.  Effect of adalimumab on the expression of genes encoding TNF-α signal paths in skin fibroblasts in vitro.

Authors:  Dominika Wcisło-Dziadecka; Joanna Gola; Beniamin Grabarek; Urszula Mazurek; Ligia Brzezińska-Wcisło; Eugeniusz J Kucharz
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.